WHN's Approach to GLP-1 Adjunct Therapy

If you’re already on a GLP-1 drug*, we urge you to take the basic WHN Weight Loss Combo at the same time as adjunct therapy.

Here’s the problem this approach is meant to solve:

• Most women quit taking their GLP-1 drug in about a year, whether due to side effects, stalled weight loss, high cost, or a combination of those factors.

• Nearly everyone who quits their GLP-1 then regains all the weight they’ve lost — which is why doctors say you have to stay on the drugs for the rest of your life to keep the weight off.

We believe there’s a better way — that you can take your GLP-1 drug to accelerate your weight loss, then stop it when you and your doctor think best… and then keep the weight off.

How? By reducing the body’s negative feedback inhibition, a well-known adaptive mechanism that applies across a range of medications:

• When you take a naturally-occurring substance as a medicine — for example, melatonin or testosterone — this reduces the body’s own production of that substance.

• GLP-1 is just such a natural substance, and its levels are reduced in your body by being overweight, prediabetic, stressed, and a host of other factors.

• When you take the WHN Weight Loss Combo and follow the WHN Diet at the same time, you support your body’s own production of GLP-1… improving your odds of keeping the weight off when you stop your prescription.

• There is as yet no clinical evidence of this claim, but we believe it is biologically plausible that using the WHN

Weight Loss Combo as adjunct therapy will reduce the factors that cause many women to plateau in their weight loss efforts even while on a GLP-1 drug.

* The main GLP-1 receptor agonist drugs are:

• Semaglutide (Ozempic, Rybelsus)

• Tirzepatide (Mounjaro, Zepbound)

• Exenatide (sold as Byetta, Bydureon)

• Liraglutide (Victoza, Saxenda)

• Albiglutide (Tanzeum)

• Dulaglutide (Trulicity)

• Lixisenatide (Adlyxin)

Questions?

Give our Advisors a call at 1-800-448-4919.  They’re here to listen and help.